Table 1.
All | Vx-001 | Placebo | ||||
---|---|---|---|---|---|---|
No of patients | % | No of patients | % | No of patients | % | |
190 | 89 | 101 | ||||
Sex | ||||||
Males | 132 | 69.5 | 60 | 67.4 | 72 | 71.3 |
Females | 58 | 30.5 | 29 | 32.6 | 29 | 28.7 |
Age | ||||||
>65 years | 99 | 52.1 | 45 | 50.6 | 54 | 53.5 |
<65 years | 91 | 47.9 | 44 | 49.4 | 47 | 46.5 |
Histology | ||||||
NSQ | 114 | 60.0 | 55 | 61.8 | 59 | 58.4 |
SQ | 72 | 37.9 | 34 | 38.2 | 38 | 37,6 |
Mixte | 4 | 2.1 | 0 | 0.0 | 4 | 4,0 |
Response to previous treatment | ||||||
OR | 88 | 46.3 | 36 | 40.4 | 52 | 51.5 |
SD | 102 | 53.7 | 53 | 59.6 | 49 | 48.5 |
ECOG | ||||||
0 | 75 | 39.5 | 33 | 37.1 | 42 | 41.6 |
1 | 115 | 60.5 | 56 | 62.9 | 59 | 58.4 |
Smoking status | ||||||
Never | 25 | 13.2 | 10 | 11.2 | 15 | 14.9 |
Smokers | 165 | 86.8 | 79 | 88.8 | 86 | 85.1 |
Heavy smokers (>25 years) | 128 | 67.4 | 62 | 69.7 | 66 | 65.3 |
Light smokers (<25 years) | 35 | 18.4 | 17 | 19.1 | 18 | 17.8 |
Missing | 2 | 1.1 | 0 | 0,0 | 2 | 2.0 |